IDYA

IDEAYA BIOSCIENCES INC

IDYA·45166A102·US·Common Stock·Healthcare - Biotechnology-13D/G

IDYA (IDEAYA BIOSCIENCES INC) is held by 144 institutional investors as of Q2 2026. Largest holders: FMR LLC ($525.9M), BlackRock, Inc. ($331.5M), Capital Research Global Investors ($199.2M). Net institutional sentiment: Mixed.

144
Holders
(9 Elite)
$2.9B
Total Value
53% (143)
Consensus
76 buying - 67 selling
13F: Insider & Congress: Updated regularly
IDYA

Smart Money Verdict

View all
Loading verdict
Held by 144 funds
9 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Jul 9, 2026 · Activists Aug 14, 2026 · Congress none

ActivistBaker Bros. Advisors LPBaker Bros. Advisors LP5.2%Aug 14, 2026
ActivistVAVanguard Capital Management5.1%Jul 31, 2026
InsiderRARuiz Briseno AndresSell $382KJul 7, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
14.1M(+7.1%)$525.9M0.0%+61.96%
34
Increased
8.9M(+5.3%)$331.5M0.0%+64.50%
33
Increased
5.3M(+3.5%)$199.2M0.0%+68.10%
32
Increased
5M(+26.9%)$186.7M0.9%+55.65%
53
Increased
4.5M(+20.3%)$169.5M0.0%+18.56%
36
Increased
4.1M(+10.7%)$154M0.0%+20.18%
34
Decreased
2.7M(-3.8%)$101.2M0.1%+70.45%
0
Decreased
2.4M(-3.0%)$90.4M0.0%+51.02%
0
Increased
1.9M(+3.8%)$72M0.0%+41.50%
31
Increased
1.7M(+24.6%)$61.9M0.0%+29.62%
36
Increased
1.6M(+1514.8%)$54.2M0.0%+13.35%
47
Decreased
1.4M(-42.8%)$53.9M0.2%+17.46%
0
Decreased
1.4M(-52.1%)$53.4M0.1%+62.33%
0
Increased
1.3M(+15.3%)$47.3M0.0%+28.11%
34
Decreased
1.2M(-25.6%)$45.9M0.0%+53.90%
0
Decreased
1.1M(-1.4%)$40.7M0.2%+45.53%
0
Increased
1M(+8.9%)$38.2M0.0%+75.15%
32
New
891,608$33.2M0.0%+11.56%
40
Decreased
851,306(-3.6%)$31.7M0.0%+24.33%
0
Increased
821,612(+10.2%)$30.6M0.0%+20.23%
32

Showing 1-20 of 151

1 / 8
IDYAIDYAIDEAYA BIOSCIENCES INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used